[1] MURAI M Y, MEENA J, SUBHASH C C. Curcumin nanomedicine: A road to cancer therapeutics.Curr Pharm Design, 2013,19(11):1994-2010.

[2] SHARMA R A,GESCHER A J,STEWARD W P, et al. Curcumin: The story so far.Eur J Cancer, 2005,41(13): 1955-1968.

[3] MOGHDAMTOUSI S Z, KADIR H A, HASSANDARVISH P, et al. A review on antibacterial, antiviral, and antifungal activity of curcumin. Bio Med Res Int, 2014,186864:1-12.

[4] ZHOU H Y, BEEVERS C S, HUANG S, et al. The targets of curcumin. Curr Drug Targets,2011,12(3):332-347.

[5] BASNET P, SKALKO B N. Curcumin: An antiinflammatory molecule from a curry spice on the path to cancer treatment. Molecules, 2011,16(6):4567-4598.

[6] LOPRESTI A L, HOOD S D, DRUMMOND P D. Multiple antidepressant potential modes of action of curcumin: A review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects.J Psychopharmacol, 2012,26(12):1512-1524.

[7] AGGARWAL B B, YUAN W, LI S Y. Curcumin-free turmeric exhibits anti-inflammatory and anticancer activities: Identification of novel components of turmeric. Mol Nutr Food Res, 2013,57(9):1529-1542.

[8] MENG B, LI Y, CAO H. Antioxidant and antiinflammatory activities of curcumin on diabetes mell-itus and its complications. Curr Pharm Design, 2013,19(11):2101-2113.

[9] KUMAR A, LI L, CHATURVEDI A, et al. Two-photon fluorescence properties of curcumin as a biocompatible marker for confocal imaging. Appl Phys Lett, 2012,100(20):1-4.

[10] EREZ Y, PRESIADO I, GEPSHTEIN R, et al. Temperature dependence of the fluorescence proper-ties of curcumin. J Phys Chem A , 2011,115(40):10962-10971.

[11] BENASSI R, FERRARI E, LAZZARI S, et al. How glucosylation triggers physical-chemical prop-erties of curcumin: An experimental and theoretical study. J Phys Org Chem, 2011,24(4):299-310.

[12] REASON W, MYSORE S V, MARILENE B W, et al. Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer ,2011,10(12):1-19.

[13] LI X Y, CHEN T K, XU L, et al. Preparation of curcumin micelles and the in vitro and in vivo ev-aluation for cancer therapy. J Biomed Nanotechnol, 2014,10(8):1458-1468.

[14] SAMPATH M, LAKRA R, KORRAPATI P, et al. Curcumin loaded poly (lactic-co-glycolic) acid nanofiber for the treatment of carcinoma. Colloid Surf B, 2014,117(5): 128-134.

[15] LIN C C, LIN H Y, CHI M H, et al. Preparation of curcumin microemulsions with food-grade soyb-ean oil/lecithin and their cytotoxicity on the HepG2 cell line. Food Chem, 2014,154(1):282-290.

[16] RATANAVARAPORN J, KANOKPANONT S, DAMRONGSAKKUL S. The development of inje-ctable gelatin/silk fibroin microspheres for the dual delivery of curcuminand piperine. J Mater Sci :Mater Med, 2014,25(2):401-410.

[17] RAO W, ZHANG W J, POVENTUD-FUENTES I, et al. Thermally responsive nanoparticle-encapsulated curcumin and its combination with mild hyperthermia for enhanced cancer cell destruction. Acta Biomater, 2014,10(2):831-842.

[18] SEETA RAMA RAJU G, PAVITRA E, GANJI P N, et al. Imaging and curcumin delivery in pancreatic cancer cell lines using PEGylated α-Gd2(MoO₄)₃ mesoporous particles. Dalton Trans, 2014,43(8):3330-3338.

[19] NAKSURIYA O, OKONGI S, SCHIFFELERS R M, et al. Curcumin nanoformulations: A review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment.Biomaterials, 2014,35(10):3365-3383.

[20] SALEM M, ROHAMI S, GILLIES E R. Curcumin, a promising anti-cancer therapeutic: A review of its chemical properties, bioactivity and approaches to cancer cell delivery. Rsc Adv, 2014,4(21):10815-10829.

[21] CHEN Q Y, ZHENG Y, JIAO D M, et al. Curcumin inhibits lung cancer cell migration and invasion through Rac1-dependent signaling pathway. J Nutr Biochem, 2014,25(2):177-185.

[22] LIM T G, LEE S Y, HUANG Z N, et al. Curcumin suppresses proliferation of colon cancer cells by targeting CDK2. Cancer Prev Res, 2014,7(4):466-474.

[23] KRONSKI E, FIORI M E, BARBIERI O, et al. MiR181b is induced by the chemopreventive poly-phenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and-2. Mol Oncol, 2014,8(3):581-595.

[24] CAI X Z, HUANG W Y, QIAO Y. Inhibitory effects of curcumin on gastric cancer cells: A proteo-mic study of molecular targets. Phytomedicine, 2013,20(6):495-505.

[25] CHIANG I T, LIU Y C, HSU F T, et al. Curcumin synergistically enhances the radiosensitivity of human oral squamous cell carcinoma via suppression of radiation-induced NF-kappa B activity.Oncol Rep, 2014,31(4):1729-1737.

[26] SLUSARZ A, SHENOUDA N S, SAKLA M S, et al. Common botanical compounds inhibit the hedgehog signaling pathway in prostate cancer. Cancer Res, 2010,70(8):3382-3390.

[27] SUN X D, LIU X E, HUANG X S. Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway. Oncol Rep, 2013,29(6):2401-2407.

[28] HE M S, LI Y, ZHANG L, et al. Curcumin suppresses cell proliferation through inhibition of the Wnt/beta-catenin signaling pathway in medulloblastoma. Oncol Rep, 2014,32(1):173-180.

[29] SUBRAMANIAM D, PONURANGAM S, RAMAMOORTHY P. Curcumin induces cell death in esophageal cancer cells through modulating notch signaling. Plos One, 2012,7(2):1-11.

[30] GAO W, CHAN J Y W, WEI W I, et al. Anti-cancer effects of curcumin on head and neck cancers. Anticancer Agents Med Chem, 2012,12(9):1110-1116.

[31] PHYLLIS L, PRIYA R D, JOSEPH D R I, et al. Coupling to a glioblastoma-directed antibody po-tentiates antitumor activity of curcumin. Int J Cancer, 2014,135( 3 ):710-719.

[32] AJAZUDDIN, SARAF S. Applications of novel drug delivery system for herbal formulations. Fitoterapia, 2010,81(7):680-689.

[33] WANG D, VEENA M S, STEVENSON K, et al. Liposome-encapsulated curcumin suppresses gro-wth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor κb by an akt-independent pathway. Clin Cancer Res, 2008,14(19):6228-6236.

[34] HASAN M, BELHAJ N, BENACHOUR H, et al. Liposome encapsulation of curcumin: Physico-chemical characterizations and effects on MCF7 cancer cell proliferation. Int J Pharm,2014,461(1-2):519-528.

[35] VITAGLIONE P, LUMAGA R B, FERRACANE R, et al. Curcumin bioavailability from enriched bread: The effect of microencapsulated ingredients. J Agric Food Chem, 2012,60(13):3357-3366.

[36] LI C, ZHANG X L, HUANG X L, et al. Preparation and characterization of flexible nanoliposomes loaded with daptomycin, a novel antibiotic, for topical skin therapy. Int J Nanomed, 2013,8(3):1285-1292.

[37] LI C, ZHANG Y, SU T T, et al. Silica-coated flexible liposomes as a nanohybrid delivery system for enhanced oral bioavailability of curcumin. Int J Nanomed, 2012,7(12):5995-6002.

[38] SAENGKRIT N, SAESOO S, SRINUANCHAI W, et al. Influence of curcumin-loaded cationic liposome on anticancer activity for cervical cancer therapy. Collodis Surf B, 2014,114(10):349-356.

[39] DHULE S S, PENFORNIS P, FRAZIER T, et al. Curcumin-loaded gamma-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma. Nanomed-Nanotechnol Biol Med, 2012,8(4):440-451.

[40] NIU Y M, DAN K, YANG Q Q, et al. Temperature-dependent stability and DPPH scavenging acti-vity of liposomal curcumin at pH 7.0. Food Chem,2012,135(3):1377-1382.

[41] LAZAR A N, MOURTAS S, YOUSSEF I, et al. Curcumin-conjugated nanoliposomes with high affinity for A beta deposits: Possible applications to Alzheimer disease. J Nano, 2012,9(5): 712-721.

[42] LU Y, DING N, YANG C, et al. Preparation and in vitro evaluation of a folate-linked liposomal curcumin formulation. J Liposome Res, 2012,22( 2): 110-119.

[43] CHU Y, LI D, LUO Y F, et al. Preparation and in vitro evaluation of glycyrrhetinic acid-modified curcumin-loaded nanostructured lipid carriers. Molecules, 2014,19(2):2445-2457.

[44] GUGULOTHU D, KULKARNI A, PATRAVALE V, et al. pH-sensitive nanoparticles of curcumin-celecoxib combination: Evaluating drug synergy in ulcerative colitis model. J Pharm Sci,2014,103(2):687-696.

[45] DAVARAN S, ALIMIRZALU S, NEJATI-KOSHKI K, et al. Physicochemical characteristics of Fe₃O₄ magnetic nanocomposites based onpoly(N-isopropylacrylamide) for anti-cancer drug deliv-ery. Asian Pac J Cancer P, 2014,15(1):49-54.

[46] ABOUZEID A H, PATEL N R, RACHMAN I M, et al. Anti-cancer activity of anti-GLUT1 antibody-targeted polymeric micelles co-loaded with curcuminand doxorubicin. J Drug Targeting,2013,21(10):994-1000.

[47] BARUI S, SAHA S, MONDAL G, et al. Simultaneous delivery of doxorubicin and curcumin encapsulated in liposomes of PEGylated RGDK-lipopeptide to tumor vasculature. Biomaterials, 2014,35(5): 1643-1656.

[48] FANG Y. Ligand-receptor interaction platforms and their applications for drug discovery. Expert Opin Drug Dis, 2012,7(10): 969-988.

[49] DANIELS T R, BERNABEU E, RODRIGUEZ J A, et al. The transferrin receptor and the targeted delivery of therapeutic agents against cancer. BBA-Gen Subjects, 2012,1820(3):291-317.

[50] MULIK R S, MONKKONEN J, JUVONEN R O, et al. Transferrin mediated solid lipid nanoparticles containing curcumin: Enhanced in vitro anticancer activity by induction of apoptosis. Int J Pharm, 2010,398(1-2):190-203.

[51] GANDAPU U, CHAITANYA R K, KISHORE G, et al. Curcumin-loaded apotransferrin nanoparticles provide efficient cellular uptake and effectively inhibit HIV-1 replication in vitro. Plos One, 2011,6(8):1-11.

[52] PIRES L A, HEGG R, FREITAS F R, et al. Effect of neoadjuvant chemotherapy on low-density lipoprotein (LDL) receptor and LDL receptor-related protein 1 (LRP-1) receptor in locally advan ced breast cancer. Braz J Med Biol Res, 2012,45(6):557-564.

[53] PANUPON K, RICARDO R, DARIN K, et al. Apolipoprotein E LDL receptor-binding domain-containing high-density lipoprotein:A nanovehicle to transport curcumin, an antioxidant and anti-amyloid bioflavonoid. Biochimica Et Biophysica Acta, 2011,18(8): 352-359.

[54] DAS M K,HUSAIN K, PATHAK Y, et al. Brain targeted delivery of curcumin using P80-PEG-coated poly(lactide-co-glycolide) nanoparticles. Asian J Chem, 2013,25(S1): 297-301.

[55] ZHANG L, ZHU W W, YANG C F, et al. A novel folate-modified self-microemulsifying drug deli-very system of curcumin for colon targeting. Int J Nanomed, 2012,7(1):151-162.

[56] MAITY A R, CHAKRABORTY A, MONDAL A, et al. Carbohydrate coated, folate functionalized colloidal graphene as a nanocarrier for bothhydrophobic and hydrophilic drugs. Nanoscale, 2014, 6(5): 2752-2758.

[57] KHATIK R, DWIVEDI P, UPADHYAY M, et al. Toxicological evaluation and targeting tumor cells through folic acid modified Guar Gum nanoparticles of curcumin. J Biomater Tiss Eng, 2014, 4(2): 143-149.

[58] D′SOUZA A A, JAIN P, GALDHAR C N, et al. Comparative in Silico-in vivo evaluation of ASGP-R ligands for hepatic targeting of curcumin Gantrez nanoparticles. AAPS J ,2013,15(3):696-706.

[59] LOPEA A F, HERCUS T R, EKERT P, et al. Molecular basis of cytokine receptor activation.IUBMB Life,2010,62(7): 509-518.

[60] SAMAH D, KARSTEN H, CLAIRE R. Autophosphorylation activation and inhibition by curcumin of the epidermal growth factor receptor reconstituted in liposomes. J Mol Recognit, 2012,25(11):623-629.

[61] KUMAR A, DAS G, BODE B. Recombinant receptor-binding domain of diphtheria toxin increases the potency of curcumin by enhancing cellular uptake. Mol Pharm, 2014,11(1):208-217.

[62] MONDAL G, BARUI S, SAHA S, et al. Tumor growth inhibition through targeting liposomally bound curcumin to tumor vasculature. J Controlled Release, 2013,172(3):832-840.

[63] ANGELA C, ENRIQUE B C, SILVIA N, et al. Immunoliposome encapsulation increases cytotoxic activity and selectivity of curcumin and resveratrol against HER2 overexpressing human breast cancer cells. Breast Cancer Res Treat, 2013,141(1):55-65.

[64] SUN S G, ZHUANG X Y, XIANG X Y, et al. A novel nanoparticle drug delivery system: The anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther,2010,18(9):1606-1614.

[65] AGGARWAL S, NDINGURI M W, SOLIPURAM R, et al. DLys(6)]-luteinizing hormone releasing hormone-curcumin conjugate inhibits pancreatic cancer cell growth in vitro and in vivo. Int J Cancer, 2011,129(7):1611-1623.

[66] WEI X, SENANAYAKE T H, WARREN G, et al. Hyaluronic acid-based nanogel-drug conjugates with enhanced anticancer activity designed for the targeting of CD44-positive and drug-resistant tumors. Bioconjugate Chem, 2013,24(4): 658-668.

[67] LIU J F, LIU J J, XU H Y, et al. Novel tumor-targeting, self-assembling peptide nanofiber as a carri-er for effective curcumin delivery. Int J Nanomed, 2014,9(1):197-207.

[68] YALLAPU M M, OTHMAN S F, CURTIS E T. Multi-functional magnetic nanoparticles for magn-etic resonance imaging and cancer therapy. Biomaterials, 2011,32(7): 1890-1905.

[69] YALLAPU M M, OTHMAN S F, CURTIS E T, et al. Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications. Int J Nanomed, 2012,7(4):1761-1779.

[70] LU W S, SHEN Y H, XIE A J, et al. Preparation and drug-loading properties of Fe₃O₄/Poly(styrene-co-acrylic acid) magnetic polymer nanocomposites. J Magn Magn Mater, 2013,345:142-146.

[71] LAM D T, HOANG N M T, TRANG T M, et al. Nanosized magnetofluorescent Fe₃O₄-curcumin conjugate for multimodal monitoring and drug targeting. Colloids Surf A, 2010,371(1-3):104-112.

[72] WANG Q J, LIU R J, SHEN X Q, et al. Mesoporous iron oxide nanofibers and their loading capa-city of curcumin. J Nanosci Nanotechno, 2014,14(4): 2871-2877.

[73] ANWER M, ASFER M, PRAJAPATI A P, et al. Synthesis and in vitro localization study of curcu min-loaded SPIONs in a micro capillary for simulating a targeted drug delivery system . Int J Pharm, 2014,468(1-2):158-164.

[74] YALLAPU M M, MAHER D M, SUNDRAM V, et al. Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth. J Ovarian Res, 2010,3(11):1-12.

[75] LI L, XIANG D G, SHIGDAR S, et al. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adeno-carcinoma cells. Int J Nanomed, 2014,9(1): 1083-1096.

[76] WANG Y M, SUN Y, WANG H, et al. Synthesis of low-molecular weight protein (LMWP) lysozy-me-curcumin conjugates for kidney drug targeting. J Biomater Sci Polym Ed, 2013,24(11):1360-1367.

[77] KHATIK R, MISHRA R, VERMA A, et al. Colon-specific delivery of curcumin by exploiting Eud ragit-decorated chitosan nanoparticles in vitro and in vivo. J Nanopart Res, 2013,15(9):1893-1908.

[78] YU Y, ZHANG X L, QIU L Y, et al. The anti-tumor efficacy of curcumin when delivered by size/charge changing multistage polymeric micelles based on amphiphilic poly(baminoester) derivates.Biomaterials, 2014,35(10):3467-3479.

[79] JI G J, YANG J H, CHEN J H, et al. Preparation of novel curcumin-loaded multifunctional nanodro plets for combining ultrasonic development and targeted chemotherapy. Int J Pharm, 2014,466(1-2):314-320.